Frank Russo Unveils Florida Medical Freedom Initiative Ballot Measure

Initiative Eliminates Physician Certification Barrier

The Medical Freedom Initiative removes the requirement that patients obtain a physician certification to access medical cannabis in Florida. Under current Florida law, codified in Florida Statutes § 381.986, patients must secure a recommendation from a state-licensed physician who's completed a Medical Marijuana Use Registry course. The proposed amendment would allow any adult Florida resident to purchase medical cannabis products from licensed Medical Marijuana Treatment Centers (MMTCs) without prior physician approval.

Read strictly, the initiative language would functionally convert Florida's medical program into an adult-use framework while maintaining the existing MMTC licensing structure. It doesn't alter the state's cap on MMTC licenses. Nor does it modify vertical-integration requirements that currently govern Florida's cannabis supply chain.

Qualifying Condition List Expands to Include Mental Health Disorders

The initiative adds six new qualifying conditions to Florida's medical cannabis program, including generalized anxiety disorder, major depressive disorder, and post-traumatic stress disorder. The current statutory list under § 381.986(1)(b) includes cancer, epilepsy, glaucoma, HIV/AIDS, Crohn's disease, Parkinson's disease, multiple sclerosis, and terminal conditions. The proposed amendment would add:

• Generalized anxiety disorder
• Major depressive disorder
• Post-traumatic stress disorder
• Chronic pain (currently covered under physician discretion)
• Insomnia
• Migraines

This expanded list mirrors condition sets in Illinois, New Jersey, and Pennsylvania. Those states saw medical patient counts increase 40-60% following similar expansions, according to state registry data.

Signature Threshold and Timeline

Russo's campaign must collect 891,589 valid signatures by February 1, 2027, to place the initiative on the November 2027 general-election ballot. Florida's constitutional-amendment process requires petition signatures equal to 8% of the votes cast in the most recent presidential election, distributed across at least half of the state's 28 congressional districts. The Division of Elections hasn't yet assigned the initiative a ballot number.

Smart & Safe Florida, the campaign behind the failed 2024 adult-use Amendment 3, spent $153 million to collect 1.2 million signatures and secure 55.9% voter approval—short of the 60% constitutional threshold. Russo hasn't disclosed funding sources or signature-collection vendors for the Medical Freedom Initiative.

Tax and Revenue Implications Under Current Framework

The initiative doesn't propose changes to Florida's existing 6% state sales tax on medical cannabis or the absence of local excise taxes. Florida is one of 12 medical-only states that apply standard sales tax to cannabis transactions without a separate excise levy. Read strictly, eliminating physician gatekeeping could increase the state's medical cannabis patient base from approximately 850,000 active cardholders to an estimated 1.8-2.3 million adults, based on participation rates in states with similarly permissive access frameworks.

At an average annual per-patient spend of $2,400, the expansion could generate an additional $2.3-3.5 billion in MMTC sales. That's $138-210 million in incremental state sales-tax revenue annually. These projections assume no federal rescheduling or IRC § 280E relief, which would alter MMTC cost structures and retail pricing.

If the initiative passes, Florida MMTCs would operate in a regulatory environment closer to Oklahoma's physician-optional medical framework than to New York's tightly controlled certification system.

MMTC Licensing and Vertical Integration Unchanged

The proposal doesn't modify Florida's 25-license cap on MMTCs or the state's mandatory vertical-integration requirement. Florida Statutes § 381.986(8)(a) limits the number of MMTC licenses and requires each licensee to cultivate, process, and dispense cannabis products under a single corporate structure. Current license holders include Trulieve (128 dispensaries), Curaleaf (68), Surterra Wellness (59), and MÜV (56), according to Florida Department of Health data as of August 2026.

For detailed background on Florida's MMTC licensing framework and patient-access rules, see the CannIntel topic hub on Florida Medical Cannabis Program.

What Comes Next

The Division of Elections has 30 days from the date of filing to review the initiative's ballot title and summary for compliance with single-subject and clarity requirements under Article XI, Section 3 of the Florida Constitution. The Florida Supreme Court must approve the ballot language before signature collection can proceed in earnest. Russo hasn't announced a petition-management firm or disclosed whether the campaign will rely on paid or volunteer circulators.

Next signal: Supreme Court review of the ballot summary, expected by mid-October 2026.